- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.04. | Jardiance doesn't cut it in post-heart attack trial | ||
| 08.04. | Carvykti, Abecma move earlier in multiple myeloma treatment | ||
| 05.04. | J&J builds in medtech with $13.1bn Shockwave buy | ||
| 05.04. | CRUK gives £58m funding for clinician scientist training | ||
| 05.04. | ADRIATIC buoys Imfinzi's prospects in early lung cancer | ||
| 05.04. | Merck taps Caris' AI expertise in ADC-focused alliance | ||
| 05.04. | Aardvark said to be planning IPO, plus other bio financings | ||
| 04.04. | Amylyx wields axe as it pulls ALS drug from the market | ||
| 04.04. | Praia emerges with $20m for digital health platform | ||
| 04.04. | Biden slams asthma inhaler prices in White House address | ||
| 04.04. | UK trials will put dementia blood tests through their paces | ||
| 04.04. | UK trials will put dementia blood tests though their paces | ||
| 04.04. | Trial finds benefit for GLP-1 agonist in Parkinson's | ||
| 04.04. | Basilea completes ceftobiprole marathon with FDA approval | ||
| 03.04. | NICE backs use of post-stroke genetic testing | ||
| 03.04. | Genmab offers $1.8bn for ADC specialist ProfoundBio | ||
| 03.04. | Neurosterix emerges with $63m for neuroscience pipeline | ||
| 03.04. | EMA starts review of Rocket's Fanconi anaemia gene therapy | ||
| 03.04. | FDA clears AI that detects heart failure using a stethoscope | ||
| 03.04. | EMA starts review of Rocket's Falconi anaemia gene therapy | ||
| 02.04. | AZ, Daiichi Sankyo file Dato-DXd for second indication | ||
| 02.04. | Acorda filed for bankruptcy, and Merz is eyeing its assets | ||
| 02.04. | Redx joins C4X Discovery in delisting from AIM due to liquidity issues | ||
| 02.04. | Ipsen licenses Sutro ADC in $900m deal | ||
| 02.04. | FDA clears first DTx for depression from Otsuka, Click |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
